A Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy
Condition:   Acute Pain Interventions:   Drug: VX-150;   Drug: hydrocodone bitartrate/acetaminophen (HB/APAP);   Drug: Placebo Sponsor:   Vertex Pharmaceuticals Incorporated Not yet recruiting - verified June 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2017 Category: Research Source Type: clinical trials

Bandage Contact Lenses for Corneal Abrasions
Conditions:   Corneal Abrasion;   Eye Trauma Interventions:   Device: Bandage contact lens;   Drug: Eyedrop;   Drug: Hydrocodone Sponsor:   Los Angeles Biomedical Research Institute Recruiting - verified June 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2017 Category: Research Source Type: clinical trials

A Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy
Condition:   Acute Pain Interventions:   Drug: VX-150;   Drug: hydrocodone bitartrate/acetaminophen (HB/APAP);   Drug: Placebo Sponsor:   Vertex Pharmaceuticals Incorporated Not yet recruiting - verified June 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2017 Category: Research Source Type: clinical trials

Bandage Contact Lenses for Corneal Abrasions
Conditions:   Corneal Abrasion;   Eye Trauma Interventions:   Device: Bandage contact lens;   Drug: Eyedrop;   Drug: Hydrocodone Sponsor:   Los Angeles Biomedical Research Institute Recruiting - verified June 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2017 Category: Research Source Type: clinical trials

A Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy
Condition:   Acute Pain Interventions:   Drug: VX-150;   Drug: hydrocodone bitartrate/acetaminophen (HB/APAP);   Drug: Placebo Sponsor:   Vertex Pharmaceuticals Incorporated Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2017 Category: Research Source Type: clinical trials

Bandage Contact Lenses for Corneal Abrasions
Conditions:   Corneal Abrasion;   Eye Trauma Interventions:   Device: Bandage contact lens;   Drug: Eyedrop;   Drug: Hydrocodone Sponsor:   Los Angeles Biomedical Research Institute Recruiting - verified June 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2017 Category: Research Source Type: clinical trials

A Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy
Condition:   Acute Pain Interventions:   Drug: VX-150;   Drug: hydrocodone bitartrate/acetaminophen (HB/APAP);   Drug: Placebo Sponsor:   Vertex Pharmaceuticals Incorporated Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2017 Category: Research Source Type: clinical trials

Bandage Contact Lenses for Corneal Abrasions
Conditions:   Corneal Abrasion;   Eye Trauma Interventions:   Device: Bandage contact lens;   Drug: Eyedrop;   Drug: Hydrocodone Sponsor:   Los Angeles Biomedical Research Institute Recruiting - verified June 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2017 Category: Research Source Type: clinical trials

A Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy
Condition:   Acute Pain Interventions:   Drug: VX-150;   Drug: hydrocodone bitartrate/acetaminophen (HB/APAP);   Drug: Placebo Sponsor:   Vertex Pharmaceuticals Incorporated Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2017 Category: Research Source Type: clinical trials

Bandage Contact Lenses for Corneal Abrasions
Conditions:   Corneal Abrasion;   Eye Trauma Interventions:   Device: Bandage contact lens;   Drug: Eyedrop;   Drug: Hydrocodone Sponsor:   Los Angeles Biomedical Research Institute Recruiting - verified June 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2017 Category: Research Source Type: clinical trials

A Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy
Condition:   Acute Pain Interventions:   Drug: VX-150;   Drug: hydrocodone bitartrate/acetaminophen (HB/APAP);   Drug: Placebo Sponsor:   Vertex Pharmaceuticals Incorporated Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2017 Category: Research Source Type: clinical trials

Comparing Five Oral Analgesics for Treatment of Acute Pain in the ED
Condition:   Musculoskeletal Pain Interventions:   Drug: oxycodone/APAP;   Drug: hydrocodone/APAP;   Drug: codeine/APAP;   Drug: 400 ibuprofen/APAP;   Drug: 800 ibuprofen/APAP Sponsor:   Albert Einstein College of Medicine, Inc. Not yet recruiting - verified May 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 30, 2017 Category: Research Source Type: clinical trials

A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of Different Amounts of Tablets of a New and a Marketed Tablet Formulation in Healthy Adults
Conditions:   Opioid-Related Disorders;   Pain, Acute;   Pain, Postoperative Interventions:   Drug: GRT7014 - Abuse Deterrend Tablet;   Drug: Norco 5Mg-325Mg Tablet Sponsor:   Grünenthal GmbH Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2017 Category: Research Source Type: clinical trials

A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of a New and a Marketed Tablet Formulation Under Fasted and Fed Conditions in Healthy Adults
Conditions:   Opioid-Related Disorders;   Pain, Acute;   Pain, Postoperative Interventions:   Drug: Norco 5Mg-325Mg Tablet;   Drug: GRT7014 - Abuse Deterrent Tablet Sponsor:   Grünenthal GmbH Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2017 Category: Research Source Type: clinical trials

A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of Different Amounts of Tablets of a New and a Marketed Tablet Formulation in Healthy Adults
Conditions:   Opioid-Related Disorders;   Pain, Acute;   Pain, Postoperative Interventions:   Drug: GRT7014 - Abuse Deterrend Tablet;   Drug: Norco 5Mg-325Mg Tablet Sponsor:   Grünenthal GmbH Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2017 Category: Research Source Type: clinical trials

A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of a New and a Marketed Tablet Formulation Under Fasted and Fed Conditions in Healthy Adults
Conditions:   Opioid-Related Disorders;   Pain, Acute;   Pain, Postoperative Interventions:   Drug: Norco 5Mg-325Mg Tablet;   Drug: GRT7014 - Abuse Deterrent Tablet Sponsor:   Grünenthal GmbH Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2017 Category: Research Source Type: clinical trials

A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of Different Amounts of Tablets of a New and a Marketed Tablet Formulation in Healthy Adults
Conditions:   Opioid-Related Disorders;   Pain, Acute;   Pain, Postoperative Interventions:   Drug: GRT7014 - Abuse Deterrend Tablet;   Drug: Norco 5Mg-325Mg Tablet Sponsor:   Grünenthal GmbH Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2017 Category: Research Source Type: clinical trials

A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of a New and a Marketed Tablet Formulation Under Fasted and Fed Conditions in Healthy Adults
Conditions:   Opioid-Related Disorders;   Pain, Acute;   Pain, Postoperative Interventions:   Drug: Norco 5Mg-325Mg Tablet;   Drug: GRT7014 - Abuse Deterrent Tablet Sponsor:   Grünenthal GmbH Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2017 Category: Research Source Type: clinical trials

A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of Different Amounts of Tablets of a New and a Marketed Tablet Formulation in Healthy Adults
Conditions:   Opioid-Related Disorders;   Pain, Acute;   Pain, Postoperative Interventions:   Drug: GRT7014 - Abuse Deterrend Tablet;   Drug: Norco 5Mg-325Mg Tablet Sponsor:   Grünenthal GmbH Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2017 Category: Research Source Type: clinical trials

A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of a New and a Marketed Tablet Formulation Under Fasted and Fed Conditions in Healthy Adults
Conditions:   Opioid-Related Disorders;   Pain, Acute;   Pain, Postoperative Interventions:   Drug: Norco 5Mg-325Mg Tablet;   Drug: GRT7014 - Abuse Deterrent Tablet Sponsor:   Grünenthal GmbH Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2017 Category: Research Source Type: clinical trials

A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of Different Amounts of Tablets of a New and a Marketed Tablet Formulation in Healthy Adults
Conditions:   Opioid-Related Disorders;   Pain, Acute;   Pain, Postoperative Interventions:   Drug: GRT7014 - Abuse Deterrend Tablet;   Drug: Norco 5Mg-325Mg Tablet Sponsor:   Grünenthal GmbH Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2017 Category: Research Source Type: clinical trials

A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of a New and a Marketed Tablet Formulation Under Fasted and Fed Conditions in Healthy Adults
Conditions:   Opioid-Related Disorders;   Pain, Acute;   Pain, Postoperative Interventions:   Drug: Norco 5Mg-325Mg Tablet;   Drug: GRT7014 - Abuse Deterrent Tablet Sponsor:   Grünenthal GmbH Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2017 Category: Research Source Type: clinical trials

A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of Different Amounts of Tablets of a New and a Marketed Tablet Formulation in Healthy Adults
Conditions:   Opioid-Related Disorders;   Pain, Acute;   Pain, Postoperative Interventions:   Drug: GRT7014 - Abuse Deterrend Tablet;   Drug: Norco 5Mg-325Mg Tablet Sponsor:   Grünenthal GmbH Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2017 Category: Research Source Type: clinical trials

A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of a New and a Marketed Tablet Formulation Under Fasted and Fed Conditions in Healthy Adults
Conditions:   Opioid-Related Disorders;   Pain, Acute;   Pain, Postoperative Interventions:   Drug: Norco 5Mg-325Mg Tablet;   Drug: GRT7014 - Abuse Deterrent Tablet Sponsor:   Grünenthal GmbH Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2017 Category: Research Source Type: clinical trials

A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of Different Amounts of Tablets of a New and a Marketed Tablet Formulation in Healthy Adults
Conditions:   Opioid-Related Disorders;   Pain, Acute;   Pain, Postoperative Interventions:   Drug: GRT7014 - Abuse Deterrend Tablet;   Drug: Norco 5Mg-325Mg Tablet Sponsor:   Grünenthal GmbH Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2017 Category: Research Source Type: clinical trials

A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of a New and a Marketed Tablet Formulation Under Fasted and Fed Conditions in Healthy Adults
Conditions:   Opioid-Related Disorders;   Pain, Acute;   Pain, Postoperative Interventions:   Drug: Norco 5Mg-325Mg Tablet;   Drug: GRT7014 - Abuse Deterrent Tablet Sponsor:   Grünenthal GmbH Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2017 Category: Research Source Type: clinical trials

A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of Different Amounts of Tablets of a New and a Marketed Tablet Formulation in Healthy Adults
Conditions:   Opioid-Related Disorders;   Pain, Acute;   Pain, Postoperative Interventions:   Drug: GRT7014 - Abuse Deterrend Tablet;   Drug: Norco 5Mg-325Mg Tablet Sponsor:   Grünenthal GmbH Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2017 Category: Research Source Type: clinical trials

A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of a New and a Marketed Tablet Formulation Under Fasted and Fed Conditions in Healthy Adults
Conditions:   Opioid-Related Disorders;   Pain, Acute;   Pain, Postoperative Interventions:   Drug: Norco 5Mg-325Mg Tablet;   Drug: GRT7014 - Abuse Deterrent Tablet Sponsor:   Grünenthal GmbH Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2017 Category: Research Source Type: clinical trials

A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of Different Amounts of Tablets of a New and a Marketed Tablet Formulation in Healthy Adults
Conditions:   Opioid-Related Disorders;   Pain, Acute;   Pain, Postoperative Interventions:   Drug: GRT7014 - Abuse Deterrend Tablet;   Drug: Norco 5Mg-325Mg Tablet Sponsor:   Grünenthal GmbH Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2017 Category: Research Source Type: clinical trials